To amend title XIX of the Social Security Act to require as a condition of receipt of full Federal medical assistance percentage under Medicaid that State Medicaid plans have in place certain drug utilization review activities.
The bill’s titles are written by its sponsor.
Sponsor and status
Marsha Blackburn
Sponsor. Representative for Tennessee's 7th congressional district. Republican.
115th Congress (2017–2019)
Provisions of this bill were incorporated into other bills which were enacted.
This bill was incorporated into:
3 Cosponsors (3 Republicans)
Position statements
What legislators are saying
“Greg Walden on combating the opioid crisis: Our communities are counting on us to deliver on solutions”
—
Rep. Greg Walden [R-OR2, 1999-2020]
(Co-sponsor)
on May 21, 2018
“Sensenbrenner Votes to Send Comprehensive Opioid Legislation to Senate”
—
Rep. James Sensenbrenner [R-WI5, 2003-2020]
on Jun 22, 2018
“Culberson Votes to Finalize House’s Historic Opioid Work”
—
Rep. John Culberson [R-TX7, 2001-2018]
on Jun 22, 2018
History
May 15, 2018
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
May 17, 2018
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
Jun 12, 2018
|
|
Reported by House Committee on Energy and Commerce
A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions. |
Jun 22, 2018
|
|
Final Bill —
Passed House (Senate next)
This activity took place on a related bill, H.R. 6 (115th), possibly in lieu of similar activity on H.R. 5799 (115th). |
Sep 17, 2018
|
|
Final Bill —
Passed Senate with Changes (back to House)
This activity took place on a related bill, H.R. 6 (115th), possibly in lieu of similar activity on H.R. 5799 (115th). |
Oct 3, 2018
|
|
Final Bill —
Senate Agreed to Changes
This activity took place on a related bill, H.R. 6 (115th), possibly in lieu of similar activity on H.R. 5799 (115th). |
Oct 24, 2018
|
|
Final Bill —
Enacted — Signed by the President
This activity took place on a related bill, H.R. 6 (115th), possibly in lieu of similar activity on H.R. 5799 (115th). |
H.R. 5799 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 5799. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 5799 — 115th Congress: Medicaid Drug Review, Utilization, Good Governance Improvement Act.” www.GovTrack.us. 2018. June 3, 2023 <https://www.govtrack.us/congress/bills/115/hr5799>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.